BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37524407)

  • 1. Redaction at the heart of NICE appraisals.
    Cave JA
    Drug Ther Bull; 2023 Sep; 61(9):130. PubMed ID: 37524407
    [No Abstract]   [Full Text] [Related]  

  • 2. Audit of data redaction practices in NICE technology appraisals from 1999 to 2019.
    Osipenko L
    BMJ Open; 2021 Oct; 11(10):e051812. PubMed ID: 34615680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NICE, in Confidence: An Assessment of Redaction to Obscure Confidential Information in Single Technology Appraisals by the National Institute for Health and Care Excellence.
    Bullement A; Taylor M; McMordie ST; Waters E; Hatswell AJ
    Pharmacoeconomics; 2019 Nov; 37(11):1383-1390. PubMed ID: 31250397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NICE appraisals should be everybody's business.
    Wells J; Cheong-Leen C
    BMJ; 2007 May; 334(7600):936-8. PubMed ID: 17478847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility values in National Institute for Health and Clinical Excellence (NICE) Technology Appraisals.
    Tosh JC; Longworth LJ; George E
    Value Health; 2011 Jan; 14(1):102-9. PubMed ID: 21211492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comment on: 'NICE, in Confidence: An Assessment of Redaction to Obscure Confidential Information in Single Technology Appraisals by the National Institute for Health and Care Excellence'.
    Garattini L; Freemantle N
    Pharmacoeconomics; 2020 Jan; 38(1):121-122. PubMed ID: 31848899
    [No Abstract]   [Full Text] [Related]  

  • 7. How Do Pharmaceutical Companies Model Survival of Cancer Patients? A Review of NICE Single Technology Appraisals in 2017.
    Gallacher D; Auguste P; Connock M
    Int J Technol Assess Health Care; 2019 Jan; 35(2):160-167. PubMed ID: 31017564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seeing the NICE side of cost-effectiveness analysis: a qualitative investigation of the use of CEA in NICE technology appraisals.
    Bryan S; Williams I; McIver S
    Health Econ; 2007 Feb; 16(2):179-93. PubMed ID: 16960851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health technology assessment - an important opportunity to inform the use of medical devices in the paediatric population: an analysis of NICE Medical Technology Guidance.
    Greasley S; Campbell M; Wall J
    Appl Health Econ Health Policy; 2023 Jul; 21(4):533-535. PubMed ID: 37149507
    [No Abstract]   [Full Text] [Related]  

  • 10. The importance of being NICE.
    Rid A; Littlejohns P; Wilson J; Rumbold B; Kieslich K; Weale A
    J R Soc Med; 2015 Oct; 108(10):385-9. PubMed ID: 26432807
    [No Abstract]   [Full Text] [Related]  

  • 11. Inclusion of Carer Health-Related Quality of Life in National Institute for Health and Care Excellence Appraisals.
    Pennington BM
    Value Health; 2020 Oct; 23(10):1349-1357. PubMed ID: 33032779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adopting medical technologies and diagnostics recommended by NICE: the Health Technologies Adoption Programme.
    Chisholm S
    Ann R Coll Surg Engl; 2014 Jul; 96(5):400-1. PubMed ID: 24992441
    [No Abstract]   [Full Text] [Related]  

  • 13. A little learning: reflections on 10 years of NICE technology appraisals.
    Longson CM
    Health Econ; 2012 Jan; 21(1):30-2. PubMed ID: 22147626
    [No Abstract]   [Full Text] [Related]  

  • 14. NICE and new: appraising innovation.
    Ferner RE; Hughes DA; Aronson JK
    BMJ; 2010 Jan; 340():b5493. PubMed ID: 20051468
    [No Abstract]   [Full Text] [Related]  

  • 15. Data briefing. NICE (National Institute for Clinical Excellence).
    Appleby J
    Health Serv J; 2000 Jun; 110(5708):32. PubMed ID: 11183800
    [No Abstract]   [Full Text] [Related]  

  • 16. National Institute for Clinical Excellence: NICE works.
    Rawlins MD
    J R Soc Med; 2015 Jun; 108(6):211-9. PubMed ID: 26085559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valuing health technologies at NICE: recommendations for improved incorporation of treatment value in HTA.
    Goldman D; Lakdawalla D; Philipson TJ; Yin W
    Health Econ; 2010 Oct; 19(10):1109-16. PubMed ID: 20842680
    [No Abstract]   [Full Text] [Related]  

  • 18. Searching for a threshold - Not so NICE..
    Mooney G; Coast J; Jan S; ; Ryan M; Wiseman V
    J Health Serv Res Policy; 2007 Jul; 12(3):190; author reply 190-1. PubMed ID: 17716427
    [No Abstract]   [Full Text] [Related]  

  • 19. NICE work--providing guidance to the British National Health Service.
    Rawlins MD
    N Engl J Med; 2004 Sep; 351(14):1383-5. PubMed ID: 15459297
    [No Abstract]   [Full Text] [Related]  

  • 20. Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development.
    Claxton K; Palmer S; Longworth L; Bojke L; Griffin S; McKenna C; Soares M; Spackman E; Youn J
    Health Technol Assess; 2012; 16(46):1-323. PubMed ID: 23177626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.